---
layout: splash
title: 유한양행 (000100)
excerpt: 유한양행의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSPI
- P:의약품
- 고PER
keywords: 유한양행, 000100
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 147,400 | <span style="color: cornflowerblue">-1.1<small>%</small></span> | P:의약품 | 81.2 | 5.4 | 0.3<small>%</small> |

<!-- more -->


> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | P:의약품 / 의약품 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 의약품(삐콤씨, 안티푸라민, 렉라자, 로수바미브, 코푸시럽 등), 생활용품(유한락스, 해피홈, 유한젠), 동물약품 |
| <span style="white-space:nowrap;">**상장**</span> | KOSPI / 1962년 11월 1일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 대표이사 조욱제 |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://www.yuhan.co.kr](http://www.yuhan.co.kr){:target="_blank"} |


> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 10&#x2011;25 | | [기업설명회(IR)개최(안내공시)              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20241025800249){:target="_blank"} |


> **주가 흐름**<a id="price"></a>

![000100](/stock/images/000100.png){: .align-center}


> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 147,400 | <span style="color: cornflowerblue">-1.1<small>%</small></span> | <span style="color: cornflowerblue">-5.1<small>%</small></span> | <span style="color: cornflowerblue">-6.1<small>%</small></span> | <span style="color: tomato">50.7<small>%</small></span> | <span style="color: tomato">106.2<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: tomato">166.8<small>%</small></span> | 50.5<small>%</small> | 3.30 | -17.3<small>%</small> | -5.3<small>%</small> | -9.7 |


> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| P:의약품 | 81.2 | 5.4 | 0.3<small>%</small> | 고PER |



{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/000100/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=000100){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A000100&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=000100){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/000100){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/000100/financial-summary){:target="_blank"} |


> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![000100](/stock/images/000100_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | 166.8<small>%</small> | 50.5<small>%</small> | 3.30 | -17.3<small>%</small> | -5.3<small>%</small> |
| 적립식[^fn_tech_metric_dca] | 92.7<small>%</small> | 50.1<small>%</small> | 1.85 | -18.0<small>%</small> | -6.5<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | 262.9<small>%</small> | 41.9<small>%</small> | 6.28 | -11.3<small>%</small> | -2.3<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | 113.7<small>%</small> | 41.4<small>%</small> | 2.75 | -15.4<small>%</small> | -6.3<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | 100.2<small>%</small> | 45.5<small>%</small> | 2.20 | -17.3<small>%</small> | -5.7<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | 104.6<small>%</small> | 47.8<small>%</small> | 2.19 | -17.3<small>%</small> | -5.9<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | 121.4<small>%</small> | 48.4<small>%</small> | 2.51 | -17.3<small>%</small> | -4.5<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | 128.8<small>%</small> | 49.9<small>%</small> | 2.58 | -17.3<small>%</small> | -5.7<small>%</small> |
| MACD[^fn_tech_metric_macd] | 63.6<small>%</small> | 39.6<small>%</small> | 1.61 | -25.5<small>%</small> | -5.7<small>%</small> |


> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![000100](/stock/images/000100_corr.png){: .align-center}

|       | [리가켐바이오](/141080/) | [알테오젠](/196170/) | [LIG넥스원](/079550/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [신한지주](/055550/) | [한화에어로스페이스](/012450/) | [NH투자증권](/005940/) |


> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![000100](/stock/images/000100_2x.png){: .align-center}


> **관련 정보**

- [P:의약품 업종 목록](/stats/sector/kospi_업종_의약품_종목/){: .btn .btn--info} [고PER 목록](/fn/fn_high_per/){: .btn .btn--info}

{% include commons/footnotes.md %}